Orthogon Therapeutics vs Spark Therapeutics
Orthogon Therapeutics vs Spark Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Orthogon Therapeutics is on 49/100 and Spark Therapeutics on 58/100.
Where each one leads
Orthogon Therapeutics
- agent readiness: 50/100 against 39/100
Spark Therapeutics
- our overall score: 58/100 against 49/100
- domain rating: 80/100 against 6/100
- funding raised: $82.8M against $34.6M
At a glance
| Measure | Orthogon Therapeutics | Spark Therapeutics |
|---|---|---|
| What it is | Developing first-in-class oral therapy for BK polyomavirus infections. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2012 | 2013 |
| Headquarters | Canton, USA | Philadelphia, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Orthogon Therapeutics | Spark Therapeutics |
|---|---|---|
| Employees | 3 | Not published |
| Total funding | $34.6M | $82.8M |
| Latest round | Follow-on | Series B |
| LinkedIn followers | 1,121 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Orthogon Therapeutics | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 58/100 |
| Traction | 44/100 | 40/100 |
| Team | 30/100 | 90/100 |
| Search visibility | 33/100 | 13/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 6/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Orthogon Therapeutics | Spark Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
What users say
| Measure | Orthogon Therapeutics | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
Orthogon Therapeutics vs Spark Therapeutics: common questions
Which is better, Orthogon Therapeutics or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Orthogon Therapeutics and Spark Therapeutics compare on the numbers?
Orthogon Therapeutics leads on agent readiness (50/100 against 39/100). Spark Therapeutics leads on our overall score (58/100 against 49/100), domain rating (80/100 against 6/100), funding raised ($82.8M against $34.6M).
What do real users say about Orthogon Therapeutics and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full Orthogon Therapeutics review and pricing or the Spark Therapeutics review and pricing. You can also browse other Orthogon Therapeutics alternatives we track.